本页面由Tiger Trade Technology Pte. Ltd.提供服务

Praxis Precision Medicines, Inc.

335.28
+3.671.11%
盘后335.280.00000.00%17:48 EST
成交量:64.87万
成交额:2.17亿
市值:91.89亿
市盈率:-25.94
高:349.32
开:332.52
低:314.39
收:331.61
52周最高:349.32
52周最低:26.70
股本:2,740.71万
流通股本:2,292.25万
量比:1.57
换手率:2.83%
股息:- -
股息率:- -
每股收益(TTM):-12.9227
每股收益(LYR):-10.2095
净资产收益率:-75.20%
总资产收益率:-45.09%
市净率:26.75
市盈率(LYR):-32.84

数据加载中...

公司资料

公司名字:
Praxis Precision Medicines, Inc.
交易所:
NASDAQ
成立时间:
2015
员工人数:
116
公司地址:
99 High Street,30th Floor,Boston,Massachusetts,United States
邮编:
02110
电话:
传真:
- -
简介:
Praxis Precision Medicines, Inc.于2015年9月22日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,将遗传见解转化为中枢神经系统(CNS)治疗方法的发展,CNS是以神经元失衡为特征的疾病。

董事

名称
职位
Dean Mitchell
Chairman of the Board
Marcio Souza
Director, President and Chief Executive Officer
Gregory Norden
Independent Director
Jeffrey B. Kindler
Independent Director
Jeffrey Chodakewitz
Independent Director
Jill DeSimone
Independent Director
Merit Cudkowicz
Independent Director
Stuart A. Arbuckle
Independent Director
William Young
Independent Director

股东

名称
职位
Marcio Souza
Director, President and Chief Executive Officer
Megan Sniecinski
Chief Operating Officer
Timothy Kelly
Chief Financial Officer
Alex Nemiroff
General Counsel and Secretary
Lauren Mastrocola
Principal Accounting Officer